Latest News and Press Releases

NEW YORK, NY, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York-based diversified Life Sciences and Pharmaceutical...

To Enhance Its Existing Intellectual Property Portfolio, the Company Filed an Additional U.S. Provisional Patent Application Directed to: Alternative Pharmaceutical Cannabinoid Delivery Systems NEW...

These Additional Classifications are: Tauri-Gum™ Cases (8 Retail Boxes) & Tauri-Gum™ Shipment Crates (48 Retail Boxes) NEW YORK, NY, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --...

NEW YORK, NY, Sept. 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a...

A HALAL Certified Product Means that the Product is Permissible or Acceptable in Accordance with Islamic Law  NEW YORK, NY, Aug. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Tauriga...

The Company Has Reported Its 5thConsecutive Month of Record Results From Its Highest Margin E-Commerce Business Segment NEW YORK, NY, Aug. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...

Each Rainbow Deluxe Sampler Pack Contains One Blister Pack of Each of the Six Distinct Tauri-Gum™ Flavors/Versions  NEW YORK, NY, July 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga...

Chesapeake Regulatory Group Will Provide Regulatory Affairs and FDA Interaction and Submission Services  NEW YORK, NY, June 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences,...

The Company’s Proposed Pharmaceutical Grade Version of Tauri-Gum™ is Being Developed for Nausea Regulation, Intended Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment(s)...

India Represents One of the Fastest Growing Global Markets for CBD Edibles and a Compelling Long-Term Opportunity for the Company NEW YORK, NY, May 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...